Peter Thiel
Peter Thiel is the President of Clarium Capital Management, a hedge fund with $6 billion under mangement. Peter co-founded PayPal and served as its Chairman and CEO until the company's sale to eBay in October 2002 for $1.5 billion. Peter's experience in finance includes managing a successful hedge fund, trading derivatives at CS Financial Products, and practicing securities law at Sullivan & Cromwell. Peter sits on the Board of Directors of the Pacific Research Institute and on the Board of Visitors of Stanford Law School. Peter received his BA in Philosophy and his JD from Stanford.
View Older Stories View More Recent Stories
-
1789 Capital Co-Leads Series B of Enhanced Games
-
Lindus Health and CDISC Collaborate on Innovative AI Initiative to Standardize Clinical Trial Data for Accelerated Research
-
Founders Fund in talks to back defense firm Anduril at $28 billion valuation, sources say
-
Peter Thiel-backed Crypto Firm Bullish Is Said To Consider IPO - Bloomberg
-
Palantir shares jump on upbeat revenue outlook as businesses adopt AI
-
Palantir advises clients against using DeepSeek's AI tech; forecasts upbeat 2025 revenue
-
Trade Republic Accelerates Growth Across Europe and Launches Localized Banking Products in Italy
-
Helion raises $425 million from SoftBank's venture arm, hits $5.4 billion valuation
-
Anti-CRO Lindus Health Raises $55M in Series B Funding to Transform the Clinical Trial Landscape
-
Denmark says it has neglected Greenland defence for years
-
Trade Republic Opens National Branches in France, Spain, and Italy. 8 Million Customers Now Manage Assets of Over 100 Billion Euro.
-
Bryan Johnson, Dave Asprey, Dr Michael Ashenden United With Olympians and Anti-Doping Experts to Forge the Future of Human Enhancement
-
Nasdaq tops NYSE in listings for 6th straight year as IPO optimism grows
-
MoneyHero (MNY) Announces CFO Resignation
-
UPDATE - MoneyHero Group Announces Resignation of Chief Financial Officer
-
MoneyHero Group Announces Resignation of Chief Financial Officer
-
Crusoe Closes $600M in Series D Round at $2.8 Billion Valuation to Power AI
-
Lindus Health Releases "All-in-One Cardiovascular CRO" Offering for Clinical Trials Serving Cardiovascular Health
-
MoneyHero Group Reports Third Quarter 2024 Results
-
Block Green Introduces Revolving Bitcoin Facility with Sam Altman-Backed Meanwhile
-
Former SpaceX engineer seeks to help end US dearth of special uranium fuel
-
Trump appoints former PayPal exec David Sacks as AI and crypto czar
-
Trade Republic Launches Stock Gifting, Ahead of the Christmas Season, to Allow Trade Republic Users to Support Their Family and Friends on Their Savings Journeys
-
MoneyHero Group to Announce Third Quarter 2024 Results
-
Lindus Health Rolls Out "All-in-One Infectious Disease CRO" Bespoke to Clinical Trials for Infectious Disease Interventions
-
Former Team USA Chief Joins Enhanced Games, Among Other Senior Hires Ahead Of 2025 Debut
-
New Study from Lindus Health Finds Patients are More Likely to Join a Clinical Trial with Telehealth Care
-
Thousands of election gamblers anticipate betting jackpot after Trump win
-
How Trump's second administration affects business: Musk, tariffs and more
-
Citrea Raises $14M to Expand Bitcoin Beyond Digital Gold
-
Lindus Health Introduces Its "All-in-One Women's Health CRO" for Clinical Trials in the Women's Health Space
-
Thiel's Palantir dumped by Norwegian investor over work for Israel
-
MoneyHero Appoints Distinguished Global Executive Wallace Pai to Board of Directors
-
New Pharmanovia Study Results Reveal Chloral Hydrate Noticeably Improves Severe Insomnia Within Two Weeks
-
AI hiring platform Mercor backed by Dorsey, Peter Thiel in $30 million fundraise
-
Mercor Raises $30M Series A at a $250M Valuation to Create Jobs with AI
-
MoneyHero Group Reports Second Quarter 2024 Results
-
Lindus Health Launches "All-in-One Ophthalmology CRO" Tailored to Clinical Trials in Ophthalmology
-
MoneyHero Group to Announce Second Quarter 2024 Results
-
JD Vance Urges Peter Thiel to Help Bankroll Trump Campaign - FT
-
Lindus Health Announces the Completion of Two Clinical Trials for Woebot Health's Digital Application for Depression and Anxiety Symptoms
-
Tech donor network co-founded by JD Vance seeks to push America to the right
-
Palantir to deploy AI products on Microsoft Azure for U.S. government agencies
-
Lindus Health Unveils "All-in-One Dermatology CRO" Offering for Dermatology Clinical Trials
-
Palantir raises annual forecasts on GenAI strength; shares surge
-
The Revealing Economics of Psychedelics
-
Morris Industries Invests in Series B Round of Strive Enterprises
-
STRIVE RAISES $30 MILLION IN SERIES B FUNDING ROUND
-
Neuralink's value jump leaves some Musk employees itching to cash out
-
BANKRUPTCY TRUSTEE JOINS DEBT HOLDERS OF GLORIFI TO PURSUE ALLEGED SABOTEURS

